News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Advances in subsidised breast cancer treatment

10 July 2005

Further advance in subsidised breast cancer treatment

New generation hormonal drugs are to be subsidised for some women with early breast cancer from 1 August 2005.

Under the decision by Government drug-funder PHARMAC, aromatase inhibitor drugs such as letrozole and anastrozole will be funded for women with early stage breast cancer who are unable to take tamoxifen.

Aromatase inhibitors are already fully funded for women with advanced breast cancer.

And PHARMAC Chief Executive Wayne McNee says that in response to comments from patients and clinicians, the agency is also reviewing all hormonal breast cancer treatments. This could lead to aromatase inhibitors being funded for all women with early stage breast cancer.

“This is the second time in a year that we have widened access to aromatase inhibitors and is further good news for women with breast cancer,” Wayne McNee says.

“It was important to take this step for women intolerant of tamoxifen as we were aware that this was a group of patients with limited subsidised treatment options available.

“During consultation we also received comments from some people that they thought aromatase inhibitors should be funded as a first-line treatment for early stage breast cancer, so in response to these comments we will be doing further work in this area.”

Wayne McNee says new funding for cancer therapies has recently become available which has helped to enable the latest decision to be advanced.

PHARMAC estimates that up to 1200 more women could be eligible for the new subsidy, and that expenditure on aromatase inhibitors will increase by more than $11 million over the next five years.


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines

Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>

Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>


Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
Jenny Abrahamson's John & Charles Enys: Castle Hill Runholders, 1864-1891

This volume will be of interest to a range of readers interested in the South Island high country, New Zealand’s natural environment, and the history of science. More>>